2025 年 C 反应蛋白检测全球市场报告

预计未来几年C反应蛋白检测市场规模将强劲成长。到 2029 年，这一数字将成长至 43.5 亿美元，复合年增长率为 5.2%。预测期内的增长将归因于肥胖率的上升、个人化医疗和生物标记、远端医疗和远端监控、疾病的早期发现以及生活方式相关的发炎。预测期内的关键趋势包括诊断测试、穿戴式健康技术、技术解决方案、策略联盟和工业 4.0 的引入方面的进步。

心血管疾病（CVD）患者数量的增加预计将推动C反应蛋白检测市场的成长。心血管疾病包括血管病变、结构性问题、血栓等心臟问题。儘管心血管疾病 (CVD) 的具体原因尚不完全清楚，但有几种因素可能会增加心血管疾病的风险。一个重要因素是与不良饮食、缺乏运动、吸烟和饮酒相关的行为风险，这会导致动脉中脂肪沉积（动脉粥状硬化）并增加血栓的风险。这些行为风险会导致血压、血糖、血脂升高、体重增加和肥胖。随着心血管疾病患者数量的增加，对用于诊断或预测潜在心血管疾病的C反应蛋白测试以及胆固醇测试的需求也在增加。例如，2023年12月，卫生指标与评估研究所报告称，2022年全球因心血管疾病死亡的人数达到1980万人，而每10万人中因缺血性心臟疾病死亡的人数为108.8人。高收缩压是心血管疾病相关伤残调整生命年 (DALY) 的主要因素，而饮食风险和空气污染已成为加剧此全球问题的重要行为和环境因素。

预计临床试验的增加将进一步推动C反应蛋白检测市场的发展。临床试验在评估医疗干预措施（包括 C 反应蛋白测试等诊断程序）的安全性、有效性和潜在益处方面发挥重要作用。这些临床试验有助于评估 CRP 测试在诊断心血管疾病和预测心臟相关疾病风险方面的准确性和有效性。截至 2023 年 5 月，ClinicalTrials.gov 上註册的临床试验有 452,604 项，其中 64,838 项正在积极寻找参与者。临床试验的增加凸显了C反应蛋白检测日益增长的重要性，并有助于扩大市场。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球C反应蛋白测试PESTEL分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
• 最终用途产业分析
• 全球C反应蛋白检测市场成长率分析
• 全球 C 反应蛋白检测市场表现：规模与成长，2019 年至 2024 年
• 全球 C 反应蛋白检测市场预测：规模与成长，2024-2029 年，2034 年
• 全球 C 反应蛋白检测总目标市场 (TAM)

第六章 市场细分

• 全球 C 反应蛋白检测市场（按检测类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 酵素免疫分析法（ELISA）
• 化学冷光免疫检测(CLIA)
• 免疫比浊法
• 全球 C 反应蛋白检测市场的应用、效能和预测，2019-2024 年、2024-2029 年、2034 年
• 糖尿病
• 类风湿性关节炎
• 心血管疾病
• 发炎性肠道疾病
• 癌症
• 其他用途
• 全球 C 反应蛋白检测市场（按最终用途、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 诊所
• 医院
• 诊断实验室
• 全球 C 反应蛋白检测市场：酵素免疫分析法试验 (ELISA) 细分市场、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 直接 ELISA
• 间接 ELISA
• 夹心 ELISA
• 全球 C 反应蛋白检测市场：化学冷光免疫检测(CLIA) 细分市场、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 基于光度计的 CLIA
• 自动化 CLIA 系统
• 全球 C 反应蛋白检测市场：免疫比浊法细分市场、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 基于比浊法的免疫比浊法测定
• 乳胶凝集免疫比浊法

第七章 区域和国家分析

• 全球 C 反应蛋白检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球 C 反应蛋白检测市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

• C 反应蛋白检测市场：竞争格局
• C 反应蛋白检测市场：公司简介
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Siemens AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Abbott Laboratories
• Aidian Oy
• Boditech Med Inc.
• Horiba Ltd.
• Laboratory Corporation
• Merck KGAA
• Randox Laboratories Limited
• Getein Biotech Inc.
• Bio-Rad Laboratories Inc.
• DiaSorin SpA
• Eurofins Scientific SE
• Inova Diagnostics Inc.
• Luminex Corporation
• Sekisui Diagnostics LLC
• Sysmex Corporation

第 32 章 全球竞争基准化分析与仪錶板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• C 反应蛋白检测市场 2029-提供最多新机会的国家
• C 反应蛋白检测市场 2029-提供最新兴机会的细分市场
• C 反应蛋白检测市场 2029-成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第 36 章 附录

C-reactive protein (CRP) testing is a diagnostic procedure that assesses the concentration of CRP in the bloodstream, a protein produced by the liver in response to inflammation. In cases of injury or infection, the body initiates inflammation as a protective mechanism. CRP testing is primarily employed to identify inflammation resulting from infections.

The primary assay methods utilized in the CRP testing market include enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and immunoturbidimetric assays. ELISA, for instance, is a technique employed to quantitatively measure human CRP levels in serum, aiding in the monitoring of conditions such as rheumatic fever and inflammatory processes. ELISA serves as a biological assay focusing on the measurement of antibodies, antigens, proteins, and glycoproteins. CRP testing is widely applied in clinical settings, hospitals, and diagnostic laboratories, contributing to the diagnosis and monitoring of various conditions such as diabetes, rheumatoid arthritis, cardiovascular diseases, inflammatory bowel disease, cancer, and others.

The c-reactive protein testing market research report is one of a series of new reports from The Business Research Company that provides c-reactive protein testing market statistics, including c-reactive protein testing industry global market size, regional shares, competitors with an c-reactive protein testing market share, detailed c-reactive protein testing market segments, market trends and opportunities, and any further data you may need to thrive in the c-reactive protein testing industry. This c-reactive protein testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The c-reactive protein testing market size has grown steadily in recent years. It will grow from $3.45 billion in 2024 to $3.55 billion in 2025 at a compound annual growth rate (CAGR) of 2.9%. The growth in the historic period can be attributed to increased inflammatory disease prevalence, cardiovascular risk assessment, increased aging population, increased healthcare infrastructure, and healthcare screening programs.

The c-reactive protein testing market size is expected to see strong growth in the next few years. It will grow to $4.35 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to rising obesity rates, personalized medicine and biomarkers, telehealth and remote monitoring, early disease detection, and lifestyle-related inflammation. Major trends in the forecast period include diagnostic testing advancements, wearable health technology, technological solutions, strategic collaborations, and industry 4.0 introduction.

The rise in cardiovascular disease (CVD) cases is expected to drive the growth of the C-reactive protein testing market. Cardiovascular diseases encompass heart conditions such as diseased vessels, structural issues, and blood clots. While the exact cause of CVD is not fully understood, several factors can increase the risk of developing it. One significant factor is behavioral risk, stemming from poor diet, insufficient physical activity, smoking, and alcohol consumption, which leads to the buildup of fatty deposits in the arteries (atherosclerosis) and heightens the risk of blood clots. These behavioral risks contribute to elevated blood pressure, glucose levels, blood lipids, weight gain, and obesity. As CVD cases rise, there is an increasing demand for C-reactive protein testing to diagnose or predict the likelihood of cardiovascular issues, similar to cholesterol testing. For example, in December 2023, the Institute for Health Metrics and Evaluation reported that global deaths from cardiovascular diseases reached 19.8 million in 2022, with ischemic heart disease accounting for 108.8 deaths per 100,000 people. High systolic blood pressure was the leading contributor to disability-adjusted life years (DALYs) associated with CVD, while dietary risks and air pollution emerged as significant behavioral and environmental factors exacerbating this global issue.

The increasing number of clinical trials is anticipated to further boost the c-reactive protein testing market. Clinical trials play a crucial role in assessing the safety, efficacy, and potential benefits of medical interventions, including diagnostic procedures like c-reactive protein testing. These trials are instrumental in evaluating the accuracy and efficacy of CRP testing in diagnosing cardiovascular diseases and predicting the risk of heart-related conditions. As of May 2023, there are 452,604 clinical studies registered on ClinicalTrials.gov, with 64,838 actively seeking participants, marking a notable increase from early 2021. This rise in clinical trials underscores the growing importance of c-reactive protein testing, contributing to the market's expansion.

A noteworthy trend in the c-reactive protein testing market is the technological advancement in measuring devices. Key players in the market are prioritizing technological innovation to strengthen their market positions. These companies are integrating next-generation c-reactive testing technologies into their methods, providing advanced solutions with benefits like maximum output and multiple usages. For example, Aidian, a Finnish-based diagnostic tests and solutions company, introduced the QuikRead go wrCRP & wrCRP+Hb kits in February 2022. This kit delivers two results, a wide range of CRP and Hb, from a single sample with one analysis. The wide-range CRP test allows for CRP readings that assess conditions like neonatal sepsis, predict disease severity in COPD, and aid in cardiovascular risk assessment. This technological advancement reflects a commitment to offering efficient and comprehensive c-reactive protein testing solutions.

Key players in the c-reactive protein testing market are prioritizing innovation by introducing new technological treatments, such as the C-Reactive Protein antigen test, to enhance their market standing and profitability. The C-Reactive Protein (CRP) antigen test is a blood test designed to measure the body's level of C-Reactive Protein, a protein produced by the liver in response to inflammation. LumiraDx Healthcare Pvt Ltd., an India-based medical technology company, launched the C-Reactive Protein antigen test in November 2022. This microfluidic immunoassay offers a quick and simple way to measure CRP levels in whole blood, providing an automated in vitro diagnostic test for healthcare professionals to use in close proximity to patients.

In June 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology company, acquired ReViral Ltd. for $525 million. This acquisition enhances Pfizer's anti-infective portfolio and reinforces its commitment to developing medicines and vaccines to combat respiratory syncytial virus (RSV). ReViral Ltd. is a UK-based biotech company that specializes in innovative therapies for viral diseases and C-reactive protein (CRP) testing.

Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMerieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the c-reactive protein testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The c-reactive protein testing market includes revenues earned by entities by devices and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

C-Reactive Protein Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on c-reactive protein testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for c-reactive protein testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The c-reactive protein testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA); Chemiluminescence Immunoassay (CLIA); Immunoturbidimetric Assays
• 2) By Application: Diabetes; Rheumatoid Arthritis; Cardiovascular Disease; Inflammatory Bowel Disease; Cancer; Other Applications
• 3) By End Use: Clinics; Hospitals; Diagnostic Laboratories
• Subsegments:
• 1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA; Indirect ELISA; Sandwich ELISA
• 2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA; Automated CLIA Systems
• 3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays; Latex Agglutination Immunoturbidimetric Assays
• Companies Mentioned: Thermo Fisher Scientific Inc.; F Hoffmann-La Roche AG; Danaher Corporation; Quest Diagnostics Incorporated; Siemens AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. C-Reactive Protein Testing Market Characteristics

3. C-Reactive Protein Testing Market Trends And Strategies

4. C-Reactive Protein Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global C-Reactive Protein Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global C-Reactive Protein Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global C-Reactive Protein Testing Market Growth Rate Analysis
• 5.4. Global C-Reactive Protein Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global C-Reactive Protein Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global C-Reactive Protein Testing Total Addressable Market (TAM)

6. C-Reactive Protein Testing Market Segmentation

• 6.1. Global C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Chemiluminescence Immunoassay (CLIA)
• Immunoturbidimetric Assays
• 6.2. Global C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diabetes
• Rheumatoid Arthritis
• Cardiovascular Disease
• Inflammatory Bowel Disease
• Cancer
• Other Applications
• 6.3. Global C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinics
• Hospitals
• Diagnostic Laboratories
• 6.4. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct ELISA
• Indirect ELISA
• Sandwich ELISA
• 6.5. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Chemiluminescence Immunoassay (CLIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Luminometer-Based CLIA
• Automated CLIA Systems
• 6.6. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Immunoturbidimetric Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nephelometry-Based Immunoturbidimetric Assays
• Latex Agglutination Immunoturbidimetric Assays

7. C-Reactive Protein Testing Market Regional And Country Analysis

• 7.1. Global C-Reactive Protein Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global C-Reactive Protein Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific C-Reactive Protein Testing Market

• 8.1. Asia-Pacific C-Reactive Protein Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China C-Reactive Protein Testing Market

• 9.1. China C-Reactive Protein Testing Market Overview
• 9.2. China C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India C-Reactive Protein Testing Market

• 10.1. India C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan C-Reactive Protein Testing Market

• 11.1. Japan C-Reactive Protein Testing Market Overview
• 11.2. Japan C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia C-Reactive Protein Testing Market

• 12.1. Australia C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia C-Reactive Protein Testing Market

• 13.1. Indonesia C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea C-Reactive Protein Testing Market

• 14.1. South Korea C-Reactive Protein Testing Market Overview
• 14.2. South Korea C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe C-Reactive Protein Testing Market

• 15.1. Western Europe C-Reactive Protein Testing Market Overview
• 15.2. Western Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK C-Reactive Protein Testing Market

• 16.1. UK C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany C-Reactive Protein Testing Market

• 17.1. Germany C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France C-Reactive Protein Testing Market

• 18.1. France C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy C-Reactive Protein Testing Market

• 19.1. Italy C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain C-Reactive Protein Testing Market

• 20.1. Spain C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe C-Reactive Protein Testing Market

• 21.1. Eastern Europe C-Reactive Protein Testing Market Overview
• 21.2. Eastern Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia C-Reactive Protein Testing Market

• 22.1. Russia C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America C-Reactive Protein Testing Market

• 23.1. North America C-Reactive Protein Testing Market Overview
• 23.2. North America C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA C-Reactive Protein Testing Market

• 24.1. USA C-Reactive Protein Testing Market Overview
• 24.2. USA C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada C-Reactive Protein Testing Market

• 25.1. Canada C-Reactive Protein Testing Market Overview
• 25.2. Canada C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America C-Reactive Protein Testing Market

• 26.1. South America C-Reactive Protein Testing Market Overview
• 26.2. South America C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil C-Reactive Protein Testing Market

• 27.1. Brazil C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East C-Reactive Protein Testing Market

• 28.1. Middle East C-Reactive Protein Testing Market Overview
• 28.2. Middle East C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa C-Reactive Protein Testing Market

• 29.1. Africa C-Reactive Protein Testing Market Overview
• 29.2. Africa C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. C-Reactive Protein Testing Market Competitive Landscape And Company Profiles

• 30.1. C-Reactive Protein Testing Market Competitive Landscape
• 30.2. C-Reactive Protein Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

31. C-Reactive Protein Testing Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Aidian Oy
• 31.3. Boditech Med Inc.
• 31.4. Horiba Ltd.
• 31.5. Laboratory Corporation
• 31.6. Merck KGAA
• 31.7. Randox Laboratories Limited
• 31.8. Getein Biotech Inc.
• 31.9. Bio-Rad Laboratories Inc.
• 31.10. DiaSorin S.p.A.
• 31.11. Eurofins Scientific SE
• 31.12. Inova Diagnostics Inc.
• 31.13. Luminex Corporation
• 31.14. Sekisui Diagnostics LLC
• 31.15. Sysmex Corporation

32. Global C-Reactive Protein Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The C-Reactive Protein Testing Market

34. Recent Developments In The C-Reactive Protein Testing Market

35. C-Reactive Protein Testing Market High Potential Countries, Segments and Strategies

• 35.1 C-Reactive Protein Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 C-Reactive Protein Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 C-Reactive Protein Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer